New CD20 alternative splice variants: molecular identification and differential expression within hematological B cell malignancies

BACKGROUND: CD20 is a B cell lineage–specific marker expressed by normal and leukemic B cells and targeted by several antibody immunotherapies. We have previously shown that the protein from a CD20 mRNA splice variant (D393-CD20) is expressed at various levels in leukemic B cells or lymphoma B cells...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Exp Hematol Oncol
Prif Awduron: Gamonet, Clémentine, Bole-Richard, Elodie, Delherme, Aurélia, Aubin, François, Toussirot, Eric, Garnache-Ottou, Francine, Godet, Yann, Ysebaert, Loïc, Tournilhac, Olivier, Caroline, Dartigeas, Larosa, Fabrice, Deconinck, Eric, Saas, Philippe, Borg, Christophe, Deschamps, Marina, Ferrand, Christophe
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2016
Pynciau:
Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4774009/
https://ncbi.nlm.nih.gov/pubmed/26937306
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40164-016-0036-3
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg